Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Online Streaming Act Bill Comes Due: Why the CRTC’s Latest Ruling Guarantees Years of Trade and Legal Battles 
The Government Tries to Make the Case for Bill C-22: Why Its Own Use Cases Reveal Disproportionate Overreach 
Tech Exodus: Why Bill C-22’s Privacy and Security Risks Will Drive Digital Services Out of the Country 
The Lawful Access Two-Headed Surveillance Monster: How Bill C-22 Went Off the Rails 
How Much Further Will Lawful Access Go?: Police Chief Tells Bill C-22 Hearing That Three Years of Metadata Retention Would Be “Ideal”
